Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.40206 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.39262 | 16 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.39915 | 16 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.33527 | 16 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.35095 | 16 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.45851 | 16 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.41705 | 16 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.36962 | 16 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.36106 | 16 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.38768 | 16 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.36821 | 15 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.36248 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.38671 | 16 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.38332 | 16 |